Other
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
CVS Health Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss increased by 373.3% to $142M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from $71M to $142M. Over 5 years (FY 2020 to FY 2025), Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss shows an upward trend with a 24.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ2 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
other_debt_securities_available_for_sale_continuous_unre_d33b47Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31M | $49M | $84M | $623M | $1.37B | $1.79B | $1.23B | $288M | $229M | $234M | $28M | $47M | $64M | $7M | $127M | $71M | $53M | $25M | $30M | $142M |
| QoQ Change | — | +58.1% | +71.4% | +641.7% | +119.4% | +30.7% | -31.4% | -76.5% | -20.5% | +2.2% | -88.0% | +67.9% | +36.2% | -89.1% | >999% | -44.1% | -25.4% | -52.8% | +20.0% | +373.3% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | -53.8% | -83.2% | -86.9% | -97.7% | -83.7% | -72.1% | -97.0% | +353.6% | +51.1% | -17.2% | +257.1% | -76.4% | +100.0% |
Range$7M – $1.79B
CAGR+37.8%
Avg YoY Growth+581.7%
Median YoY Growth-35.5%
Current Streak2 quarters growth
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss?
- CVS Health (CVS) reported debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss of $142M in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss changed year-over-year?
- CVS Health's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss increased by 100.0% year-over-year, from $71M to $142M.
- What is the long-term trend for CVS Health's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss?
- Over 5 years (2020 to 2025), CVS Health's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss has grown at a 24.6% compound annual growth rate (CAGR), from $10M to $30M.